As federal support becomes less predictable, universities are testing how far other funding sources can protect research without redirecting it.
For decades the federal government has been the financial foundation of American academic research. That source now looks less dependable, forcing research universities to confront a question many have deferred. What happens when the largest source of support becomes a source of disruption?
U.S. colleges and universities spent $117.7 billion on research and development in fiscal year 2024, an 8.1% increase from the previous year, according to the National Center for Science and Engineering Statistics (NCSES). Federal sources supplied more than $64 billion, or 55% of the total. The Department of Health and Human Services, which includes the National Institutes of Health (NIH), accounted for $35.5 billion alone.
That dependence is even greater in specific fields. Federal dollars funded 80% of academic R&D in atmospheric science and meteorology, 77% in aerospace engineering, 73% in electrical and communications engineering, and 71% in physics. As such, a delay, cancellation, or change in reimbursement policy can threaten not only a single project but also the employees, laboratories, and specialized infrastructure built around it.
The huge reduction in 2025 funding turned that structural exposure into an operational crisis. Harvard University reported receiving a wave of project termination notices from the NIH, National Science Foundation, Department of Defense, and Department of Energy. In response, it committed $250 million in central funding for one year, supplemented by school-level resources to support affected research. Harvard’s leaders explicitly cautioned that institutional money could provide transitional support, but not a long-term substitute for reduced federal funding.
That distinction is key. Bridge funding can preserve lab samples, complete a data collection cycle, retain essential staff through a project’s end, or keep an early-career scientist from losing years of research work. However, it cannot reproduce the scale or duration of the federal research system.
Targeted Bridge Funding
The University of Cincinnati’s 2026 bridge funding program illustrates a more targeted model. It was limited to investigators with a history of federal support who experienced a disruption beyond their control and were pursuing new external funding. Rice University announced a similar program in 2025 for faculty whose federal support was unexpectedly terminated or reduced.
Universities can make these programs more strategic by establishing priorities before a crisis. Leaders can identify projects with obligations to human research participants, irreplaceable specimens, time-sensitive experiments, community partnerships, or unusually high shutdown costs. They can also protect graduate students, postdoctoral researchers, and new faculty whose salaries and career progression often depend on a single award.
A 2026 study of early-career researchers affected by these reductions found that grant terminations and uncertainty interrupted training and weakened confidence in academic career paths. Institutions should not allocate emergency support solely according to the size of an investigator’s previous portfolio. A relatively small award may have greater long-term value when it allows a new laboratory to survive or a doctoral student to finish.
Stress-Testing the Portfolio
Stress testing should begin with a portfolio map. Research leaders need to identify which units depend most heavily on a single agency, which grants support clusters of employees, which facilities require continuous operation, and how long unrestricted reserves could sustain them. Scenario planning should account for delayed awards, abrupt terminations, lower indirect-cost reimbursements, and a prolonged decline in new grants.
Stanford University, facing federal funding uncertainty, continued a staff hiring freeze into 2026 and limited capital and facilities spending to its most critical or externally funded projects.
The Limits of Diversification
Diversification is the next line of defense, but the numbers reveal its limits. In 2024, businesses supplied 5.4% of academic R&D funding, nonprofits 5.7%, and state and local governments 5.2%, according to NCSES. Those sources are meaningful, but together they still accounted for less than one-third of the federal share.
Few examples capture both the ingenuity and inadequacy of alternative funding better than OnlyMarms. In 2026, UCLA ecologist Daniel Blumstein and collaborators launched the family-friendly OnlyFans account to support a yellow-bellied marmot study at the Rocky Mountain Biological Laboratory in Colorado. The project, which began in 1962, is among the world’s longest-running studies of individually identified mammals.
OnlyMarms initially raised $6,000. An unofficial marmot-themed cryptocurrency created by supporters subsequently pushed total fundraising above $100,000, enough to continue the research for another year. The viral success offered a lifeline and generated public interest, but it also exposed the fragility of asking long-term research to depend on novelty, public generosity, and social media attention.
These alternative funding sources also serve different purposes. Industry partners are often most interested in applied research with commercial potential. Philanthropists can support emerging ideas or neglected fields, but gifts may be restricted by donor intent and can shift with financial markets or priorities. States tend to invest in research tied to regional industries, workforce needs, or economic development. None is naturally positioned to sustain the full range of basic, long-horizon, and public-interest research supported by federal agencies.
Collaboration and Its Risks
Collaboration can stretch existing dollars further. Agreements among five Oregon public research institutions lowered barriers to using specialized facilities across their campuses and could reduce some user fees by as much as 25%. Such arrangements allow them to share expensive instruments and technical staff, reducing project expenses.
Research consortia can similarly pool expertise, infrastructure, and administrative capacity. They can make smaller institutions more competitive and give industry or state partners a single point of entry. Yet, shared projects require clear rules for governance, publication, data access, and intellectual property. Without them, collaboration could exchange financial risk for conflict.
The same concern applies to diversification more broadly. Outside funding is never neutral. Government agencies define priorities through appropriations and grant programs, corporations favor work aligned with their business strategy, and donors choose causes they value. The American Association of University Professors has warned that large strategic corporate alliances may allow sponsors to influence research portfolios, resources, and internal governance.
Building Guardrails
Universities therefore need guardrails as much as they need new revenue. Sponsored-research agreements should preserve researchers’ ability to publish, disclose conflicts of interest, protect students’ degree progress, and prevent sponsors from controlling methods or conclusions. Gift agreements should be reviewed for conditions that compromise faculty authority or institutional independence. Leaders should also track whether their research portfolio is being steered toward projects with obvious commercial or political appeal while leaving foundational scholarship behind.
The goal is not to replace one dominant funding source with several smaller ones. It’s to build enough flexibility so no single disruption can immediately dismantle teams, careers, or essential research capacity. Federal support remains the only source operating at the scale of the national academic research enterprise; however, planning ahead and thinking creatively can create resilience. Institutions will protect their public mission only if they treat independence, transparency, and talent as assets worth financing, not costs to be cut when the money becomes uncertain.









